388 related articles for article (PubMed ID: 19536876)
1. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.
Ognjanovic S; Linabery AM; Charbonneau B; Ross JA
Cancer; 2009 Sep; 115(18):4218-26. PubMed ID: 19536876
[TBL] [Abstract][Full Text] [Related]
2. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
Turner JH; Richmon JD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
[TBL] [Abstract][Full Text] [Related]
3. Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre.
Drabbe C; Benson C; Younger E; Zaidi S; Jones RL; Judson I; Chisholm J; Mandeville H; Fisher C; Thway K; Al Muderis O; Messiou C; Strauss D; Husson O; Miah A; Van der Graaf WTA
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):e27-e35. PubMed ID: 31350181
[TBL] [Abstract][Full Text] [Related]
4. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyosarcoma in children: a SEER population based study.
Perez EA; Kassira N; Cheung MC; Koniaris LG; Neville HL; Sola JE
J Surg Res; 2011 Oct; 170(2):e243-51. PubMed ID: 21529833
[TBL] [Abstract][Full Text] [Related]
6. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.
Gerber NK; Wexler LH; Singer S; Alektiar KM; Keohan ML; Shi W; Zhang Z; Wolden S
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):58-63. PubMed ID: 23414767
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
8. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.
Ognjanovic S; Carozza SE; Chow EJ; Fox EE; Horel S; McLaughlin CC; Mueller BA; Puumala S; Reynolds P; Von Behren J; Spector L
Br J Cancer; 2010 Jan; 102(1):227-31. PubMed ID: 19997102
[TBL] [Abstract][Full Text] [Related]
9. A review of pediatric middle ear tumors and analysis of the demographics, management, and survival of pediatric rhabdomyosarcomas of the middle ear.
Janz TA; Camilon PR; Cheung AY; Nguyen SA; White DR; Weber PC
Int J Pediatr Otorhinolaryngol; 2018 Sep; 112():109-112. PubMed ID: 30055718
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis.
Amer KM; Thomson JE; Congiusta D; Dobitsch A; Chaudhry A; Li M; Chaudhry A; Bozzo A; Siracuse B; Aytekin MN; Ghert M; Beebe KS
J Orthop Res; 2019 Oct; 37(10):2226-2230. PubMed ID: 31161653
[TBL] [Abstract][Full Text] [Related]
11. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
[TBL] [Abstract][Full Text] [Related]
12. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
13. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017.
McEvoy MT; Siegel DA; Dai S; Okcu MF; Zobeck M; Venkatramani R; Lupo PJ
Cancer Med; 2023 Feb; 12(3):3644-3656. PubMed ID: 36069287
[TBL] [Abstract][Full Text] [Related]
14. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Allen-Rhoades W; Lupo PJ; Scheurer ME; Chi YY; Kuttesch JF; Venkatramani R; Meyer WH; Mascarenhas L
Cancer Med; 2023 May; 12(9):10222-10229. PubMed ID: 37016270
[TBL] [Abstract][Full Text] [Related]
15. The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study.
Van Gaal JC; Van Der Graaf WT; Rikhof B; Van Hoesel QG; Teerenstra S; Suurmeijer AJ; Flucke UE; Loeffen JL; Sleijfer S; De Bont ES
Anticancer Res; 2012 Oct; 32(10):4485-97. PubMed ID: 23060577
[TBL] [Abstract][Full Text] [Related]
16. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.
Crose LE; Etheridge KT; Chen C; Belyea B; Talbot LJ; Bentley RC; Linardic CM
Clin Cancer Res; 2012 Jul; 18(14):3780-90. PubMed ID: 22648271
[TBL] [Abstract][Full Text] [Related]
17. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
Raney RB; Stoner JA; Walterhouse DO; Andrassy RJ; Donaldson SS; Laurie F; Meyer WH; Qualman SJ; Crist WM;
Pediatr Blood Cancer; 2004 Jun; 42(7):618-25. PubMed ID: 15127417
[TBL] [Abstract][Full Text] [Related]
18. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
[TBL] [Abstract][Full Text] [Related]
19. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058
[TBL] [Abstract][Full Text] [Related]
20. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?
Blakely ML; Lobe TE; Anderson JR; Donaldson SS; Andrassy RJ; Parham DM; Wharam MD; Qualman SJ; Wiener ES; Grier HE; Crist WM
J Pediatr Surg; 1999 May; 34(5):736-41; discussion 741-2. PubMed ID: 10359174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
